86,762 verified 4-option questions Double-checked by independent solution

ExCPT · Dispensing Process · 6 min read

Containers, Unit-Dose Repackaging and OTC Selection

In this lesson you will
  • Identify standard prescription container types, child-resistant packaging standards under the Poison Prevention Packaging Act, and legal packaging exemptions.
  • Describe unit-dose repackaging formats, mandatory package labeling, beyond-use date limitations, and required control log documentation.
  • Differentiate the pharmacy technician's authorized scope from the pharmacist's clinical responsibilities regarding over-the-counter selection, behind-the-counter sales, and prescription counseling.

Prescription Containers and Child-Resistant Packaging Standards

Selecting the correct container is essential for preserving the chemical stability of a dispensed drug. Solid oral dosage forms, including tablets and capsules, are typically dispensed in amber plastic prescription vials. Amber vials reduce light exposure, but a medication must be dispensed in its required light-resistant or original container when its labeling specifies one. Prescription vial sizes are standardly measured in drams. In contrast, liquid prescription bottles are standardly measured in fluid ounces or milliliters. Specialized dosage forms require dedicated container designs: ointment jars and collapsible metal or plastic tubes are used to package topical semi-solid formulations, while dropper bottles are specialized containers used for the administration of liquid ophthalmic and otic medications. Furthermore, products designed for use in their original manufacturer packaging, such as metered-dose inhalers and blister-packed oral contraceptives, are generally dispensed directly in that packaging.

Patient safety extends beyond chemical preservation to accidental ingestion prevention. The Poison Prevention Packaging Act requires child-resistant closures on the vast majority of oral prescription drugs. To qualify as child-resistant under federal testing standards, at least 85% of tested children under five years of age must be unable to open the container before a demonstration, and at least 80% must remain unable to open it after a demonstration. Additionally, the standard requires accessibility for older adults: at least 90% of tested adults ages 50 to 70 must be able to open and properly reclose the packaging. To accommodate varying patient needs, many pharmacies utilize reversible caps, which provide a child-resistant mechanism on one side and an easy-open screw cap on the other.

Important exemptions exist under the law. For instance, sublingual nitroglycerin tablets are legally exempt from the requirement for child-resistant packaging because patients experiencing acute cardiac symptoms must be able to open the container immediately without difficulty. In inpatient environments, prescription medications administered to institutionalized patients by healthcare personnel are generally exempt from child-resistant packaging requirements. For ambulatory retail patients, a patient may make a blanket request, preferably in writing, to receive all of their prescription medications with non-child-resistant closures. Prescribers have different limits: a prescriber can request a non-child-resistant closure for an individual prescription, but cannot make a blanket request covering all of a patient's prescriptions.

Exam tip. Pay close attention to who can authorize easy-open caps. A patient can make a blanket request covering all of their prescriptions (preferably in writing), but a prescriber may only request a non-child-resistant cap for an individual prescription. Also remember that sublingual nitroglycerin tablets are legally exempt from child-resistant closures.

Common mistakes

  • Believing a prescriber can issue a blanket request for non-child-resistant caps across all of a patient's prescriptions; prescribers may only request non-child-resistant closures on an individual prescription basis, while only the patient can make a blanket request.
  • Assigning a beyond-use date to a repackaged non-sterile oral drug that extends past the original manufacturer's expiration date.
  • Providing dosage recommendations, pediatric dosing guidance, or therapeutic OTC product suggestions to a customer instead of referring them to the pharmacist.
  • Attempting to counsel a patient on a prescription drug; technicians may only convey the offer of counseling where permitted by state law, while the actual counseling must be performed by a pharmacist or an authorized intern under pharmacist supervision.

Key points

  • Solid oral medications are often dispensed in amber vials measured in drams, but products that require their original or another specified container must remain in that container; liquids are commonly dispensed in bottles measured in fluid ounces or milliliters, and topical semi-solids may be packaged in jars or collapsible tubes.
  • The Poison Prevention Packaging Act requires child-resistant closures (tested to block 85%/80% of children under five while allowing 90% of adults aged 50 to 70 to open and reclose) on most oral prescriptions, exempting sublingual nitroglycerin and institutional administrations.
  • Refrigerated and frozen shipments require packaging validated to maintain each product’s specified temperature range; 2 to 8 °C is common for refrigerated products, and appropriate cooling materials and temperature monitors may be used.
  • Unit-dose systems can reduce errors and waste; oral liquid unit doses may be supplied in suitable sealed cups, oral syringes that cannot connect to hypodermic needles, bottles, or manufacturer-packaged containers, with oral syringes labeled 'for oral use only'.
  • Repackaged unit-dose labels must include the required drug identification, strength, dosage form, assigned beyond-use date, lot number, and manufacturer or repackager identification; the beyond-use date must not exceed the manufacturer's expiration date.
  • Repackaging control logs require drug details, lot numbers, dates, quantity, and initials from both the technician and verifying pharmacist, with final verification reserved exclusively for the pharmacist.
  • Technicians may locate OTC items and read Drug Facts labels, but must refer clinical selection, interactions, and pediatric dosing to the pharmacist; federal law mandates photo identification and logbook recording for behind-the-counter pseudoephedrine sales.

Practice this section

Explained ExCPT Dispensing Process questions, no account needed. ExCPT Dispensing Process practice test

Study guide included with ExCPT plans

The full lesson continues with 3 more sections with exam tips, audio in English and Spanish, 5 Check yourself questions and 20 flashcards.

  • 1 month$44.99 $22.49
  • 3 months$131.99 $65.99
  • Lifetime$269.99 $134.99

One payment, no subscription.

See ExCPT plans

Already a member? Log in

Sample lesson: Prescription Components, Types and Prescriber Authority

25 practice questions on this exam

Each ExCPT practice test has 25 original questions with the answers explained. No account needed.

Open the ExCPT practice tests
All ExCPT lessons

Original lesson written for ExCPT practice · updated October 31, 2026. Exam names are trademarks of their owners; tests.global is not affiliated with them.